Table 2.
Electromyography (EMG) and nerve conduction velocity (NCV) tests before and after UG-MNES treatment.
| EMG (APB) | Time-point i | Time-point iv |
|---|---|---|
| Lat (ms) | 11.0 | 10.8 |
| Amp (mV) | 364 | 367 |
| Multinomial wave | 10.1 | 10.9 |
| Early recruitment | Interference term | Interference term |
| NCV | MNCV | SNCV | ||
|---|---|---|---|---|
| Time-point i | Time-point iv | Time-point i | Time-point iv | |
| Lat (ms) | 2.86 | 3.65 | 2.44 | 2.31 |
| Amp (mV) | 12.5 | 12.4 | 30.1 | 31.5 |
| Dist (mm) | 200 | 195 | 115 | 115 |
| CV (ms) | 54.6 | 57.9 | 53.6 | 54.2 |
| Stim (mA) | 30.1 | 30.4 | 16.5 | 16.5 |
Time-point i, before treatment; Time-point iv, 1 week after the fourth intervention; EMG, electromyography; APB, abductor pollicis brevis; NCV, nerve conduction velocity; MNCV, motor nerve conduction velocity; SNCV, sensory nerve conduction velocity; Lat, latency; Amp, amplitude; Dist, distance; CV, conduction velocity; Stim, stimulation.